|
APRE
|
Aprea Therapeutics, Inc.
|
US
|
NASDAQ
|
|
APTO
|
Aptose Biosciences, Inc.
|
US
|
NASDAQ
|
|
AVEO
|
AVEO Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
BYSI
|
BeyondSpring, Inc.
|
US
|
NASDAQ
|
|
GTBP
|
GT Biopharma, Inc.
|
US
|
NASDAQ
|
|
IKNA
|
Ikena Oncology, Inc.
|
US
|
NASDAQ
|
|
IOBT
|
IO Biotech, Inc.
|
US
|
NASDAQ
|
|
KTRA
|
Kintara Therapeutics, Inc.
|
US
|
NASDAQ
|
|
POAI
|
Predictive Oncology Inc.
|
US
|
NASDAQ
|
|
PSNL
|
Personalis, Inc.
|
US
|
NASDAQ
|
|
RPTX
|
Repare Therapeutics Inc.
|
US
|
NASDAQ
|
|
SNDX
|
Syndax Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
DMPWW
|
Delmar Pharmaceuticals Inc - Warrants [16/08/202
|
US
|
OTC
|
|
VDRM
|
Viaderma Inc
|
US
|
OTC
|
|
APC
|
Advanced Proteome Therapeutics Corporation
|
CA
|
TSXV
|
|
BVX
|
BiVictriX Therapeutics Plc
|
UK
|
LSE
|
|
ETX
|
E-Therapeutics Plc
|
UK
|
LSE
|
|
PPGN
|
PolyPeptide Group AG
|
CH
|
SW
|
|
AVCTF
|
Avacta Group Plc
|
US
|
OTC
|
|
04X
|
PERSONALIS INC. DL-001
|
DE
|
F
|